These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1382 related items for PubMed ID: 17308159

  • 1. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?
    Rosano GM, Vitale C, Fini M.
    Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159
    [Abstract] [Full Text] [Related]

  • 2. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM, Fini M.
    Int J Fertil Womens Med; 2001 Dec; 46(5):248-56. PubMed ID: 11720197
    [Abstract] [Full Text] [Related]

  • 3. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
    Rosano GM, Maffei S, Andreassi MG, Vitale C, Vassalle C, Gambacciani M, Stramba-Badiale M, Mercuro G.
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
    [Abstract] [Full Text] [Related]

  • 4. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
    Koledova VV, Khalil RA.
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
    [Abstract] [Full Text] [Related]

  • 5. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence.
    Harman SM, Naftolin F, Brinton EA, Judelson DR.
    Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750
    [Abstract] [Full Text] [Related]

  • 6. The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition.
    Naftolin F, Taylor HS, Karas R, Brinton E, Newman I, Clarkson TB, Mendelsohn M, Lobo RA, Judelson DR, Nachtigall LE, Heward CB, Hecht H, Jaff MR, Harman SM, Women's Health Initiative.
    Fertil Steril; 2004 Jun; 81(6):1498-501. PubMed ID: 15193467
    [Abstract] [Full Text] [Related]

  • 7. Menopause and stroke and the effects of hormonal therapy.
    Lobo RA.
    Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
    [Abstract] [Full Text] [Related]

  • 8. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Stramba-Badiale M.
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
    [Abstract] [Full Text] [Related]

  • 9. Postmenopausal hormones and coronary artery disease: potential benefits and risks.
    Lobo RA.
    Climacteric; 2007 Oct; 10 Suppl 2():21-6. PubMed ID: 17882668
    [Abstract] [Full Text] [Related]

  • 10. [Hormone replacement therapy of menopause, heart and blood vessels].
    Kuttenn F, Gerson M.
    Arch Mal Coeur Vaiss; 2001 Jul; 94(7):685-9. PubMed ID: 11494629
    [Abstract] [Full Text] [Related]

  • 11. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
    Brinton RD.
    Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
    [Abstract] [Full Text] [Related]

  • 12. Preserving cardiovascular benefits of hormone replacement therapy.
    Bush TL.
    J Reprod Med; 2000 Mar; 45(3 Suppl):259-73. PubMed ID: 10756507
    [Abstract] [Full Text] [Related]

  • 13. KEEPS: The Kronos Early Estrogen Prevention Study.
    Harman SM, Brinton EA, Cedars M, Lobo R, Manson JE, Merriam GR, Miller VM, Naftolin F, Santoro N.
    Climacteric; 2005 Mar; 8(1):3-12. PubMed ID: 15804727
    [Abstract] [Full Text] [Related]

  • 14. Sex hormones and the cardiovascular system: effects on arterial function in women.
    Teede HJ.
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):672-6. PubMed ID: 17581228
    [Abstract] [Full Text] [Related]

  • 15. Hormones and cardiovascular health in women.
    ESHRE Capri Workshop Group.
    Hum Reprod Update; 2006 Jul; 12(5):483-97. PubMed ID: 16807276
    [Abstract] [Full Text] [Related]

  • 16. Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease.
    Prentice RL, Langer RD, Stefanick ML, Howard BV, Pettinger M, Anderson GL, Barad D, Curb JD, Kotchen J, Kuller L, Limacher M, Wactawski-Wende J, Women's Health Initiative Investigators.
    Am J Epidemiol; 2006 Apr 01; 163(7):589-99. PubMed ID: 16484450
    [Abstract] [Full Text] [Related]

  • 17. Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen.
    Dubey RK, Imthurn B, Barton M, Jackson EK.
    Cardiovasc Res; 2005 May 01; 66(2):295-306. PubMed ID: 15820198
    [Abstract] [Full Text] [Related]

  • 18. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.
    Grodstein F, Manson JE, Stampfer MJ.
    J Womens Health (Larchmt); 2006 May 01; 15(1):35-44. PubMed ID: 16417416
    [Abstract] [Full Text] [Related]

  • 19. Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial.
    Prentice RL, Langer R, Stefanick ML, Howard BV, Pettinger M, Anderson G, Barad D, Curb JD, Kotchen J, Kuller L, Limacher M, Wactawski-Wende J, Women's Health Initiative Investigators.
    Am J Epidemiol; 2005 Sep 01; 162(5):404-14. PubMed ID: 16033876
    [Abstract] [Full Text] [Related]

  • 20. Hormone replacement therapy and the cardiovascular system lessons learned and unanswered questions.
    Ouyang P, Michos ED, Karas RH.
    J Am Coll Cardiol; 2006 May 02; 47(9):1741-53. PubMed ID: 16682298
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 70.